Financial reports
10-K
2023 FY
Annual report
11 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Current reports
8-K/A
Financial Statements and Independent Auditor’s Report
15 Sep 23
8-K
Other Events
29 Aug 23
8-K
Departure of Directors or Certain Officers
12 Jul 23
8-K
Entry into a Material Definitive Agreement
6 Jul 23
8-K
Changes in Control of Registrant
13 Feb 23
8-K
Termination of a Material Definitive Agreement
5 Oct 22
8-K/A
Entry into a Material Definitive Agreement
6 May 22
8-K
Entry into a Material Definitive Agreement
21 Apr 22
8-K
Entry into a Material Definitive Agreement
13 Dec 21
8-K
Amendments to Articles of Incorporation or Bylaws
3 Dec 21
Registration and prospectus
D
$800.00 k in equity, sold $800.00 k, 5 investors
23 Jan 23
D
Indefinite amount in equity, 11 investors
9 Sep 21
D
$420K in equity, sold $420K, 12 investors
21 Jan 21
D
$125K in equity, sold $125K, 1 investor
29 Dec 17
424B3
Prospectus supplement
22 Sep 15
S-3
Shelf registration
10 Sep 15
D
$13 in options, sold $13, 10 investors
27 Aug 15
424B5
Prospectus supplement for primary offering
14 Aug 15
424B5
Prospectus supplement for primary offering
22 Jul 15
S-3/A
Shelf registration (amended)
29 May 14
Other
EFFECT
Notice of effectiveness
21 Sep 15
UPLOAD
Letter from SEC
18 Sep 15
CORRESP
Correspondence with SEC
18 Sep 15
EFFECT
Notice of effectiveness
26 Jun 14
CORRESP
Correspondence with SEC
24 Jun 14
CORRESP
Correspondence with SEC
29 May 14
UPLOAD
Letter from SEC
23 May 14
CT ORDER
Confidential treatment order
21 Apr 14
CT ORDER
Confidential treatment order
22 Mar 12
EFFECT
Notice of effectiveness
18 Apr 08